CMAB BioPharma (Suzhou)
Latest round
- Series B
Last raised
- Feb 2019
Total raised
- $72M
Investors
- 8
About CMAB BioPharma (Suzhou)
Founded in 2017, CMAB BioPharma (Suzhou) Inc. specializes in biopharmaceuticals, particularly in the area of biologics. The CEO is Yongzhong Wang, who has experience in the biopharmaceutical field.CMAB BioPharma specializes in advanced biotechnological solutions aimed at enhancing agricultural productivity and sustainability. The company’s core offerings include a range of bio-based products designed to improve soil health, increase crop yield, and support pest management. These products utilize natural microorganisms and nutrients to promote plant growth, enhance resistance to diseases, and optimize fertilizer use.CMAB BioPharma generates revenue through a structured model that includes direct sales to agricultural businesses and subscriptions for ongoing support and product replenishment. Transactions typically occur through partnerships with distributors who supply the products to end-users, including farmers and agribusinesses. The company offers various pricing plans based on the scale and type of products acquired. Flagship products, known for their efficacy and reliability, command a premium in the market, reflecting the value they provide to customers.CMAB BioPharma plans to expand its product offerings, with new products currently in development aimed at enhancing agricultural practices. The company is targeting expansion into additional markets in Europe and Asia by the end of 2022. The acquisition by WuXi Biologics will also provide additional resources and expertise to facilitate these growth plans.
Who invested in CMAB BioPharma (Suzhou)
8 investors across 3 rounds
See all investors in CMAB BioPharma (Suzhou)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CMAB BioPharma (Suzhou)
Who invested in CMAB BioPharma (Suzhou)?
CMAB BioPharma (Suzhou) has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CMAB BioPharma (Suzhou) raised?
CMAB BioPharma (Suzhou) has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CMAB BioPharma (Suzhou) last raise money?
CMAB BioPharma (Suzhou)'s most recent round on record is a Series B, in Feb 2019.
What does CMAB BioPharma (Suzhou) do?
Founded in 2017, CMAB BioPharma (Suzhou) Inc.
Where is CMAB BioPharma (Suzhou) headquartered?
CMAB BioPharma (Suzhou) is headquartered in Suzhou, China.
Which VCs invest in companies like CMAB BioPharma (Suzhou)?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at CMAB BioPharma (Suzhou)'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like CMAB BioPharma (Suzhou)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.